Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-Opioid Pain Management After Mohs Reconstruction: An Investigator-Initiated, Prospective, Randomized Clinical Trial of Suzetrigine vs Hydrocodone/Acetaminophen

NCT07575230 is registered in ClinicalTrials.gov with Baylor Research Institute as lead sponsor.

NCT NCT07575230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07575230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-Opioid Pain Management After Mohs Reconstruction: An Investigator-Initiated, Prospective, Randomized Clinical Trial of Suzetrigine vs Hydrocodone/Acetaminophen
Lead sponsor
Baylor Research Institute
Phase
Phase 4
Overall status
Enrolling by invitation
Start date
November 3, 2025
Completion date
December 31, 2027
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous tumors, mohs micrographic surgery